ESTA · NASDAQ · Medical - Devices

Establishment Labs (ESTA)

Develops breast implants, tissue expanders, and a minimally invasive enhancement procedure.

$70.24
After-hours close−0.04 (−0.06%)
At close$70.28(+3.75%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue393237444045415154656068
Cost of revenue121113151514141616191820
Gross profit262124292630283538464248
474333383949454942494952
Research & development764555555555
Selling, general & administrative40372933344440443744440
Other expenses0000000000047
Operating income−21−22−9−9−13−19−17−14−4−4−7−4
−8−1−7−7−3−17−3−1−7−8−7−7
Interest income010100000000
Interest expense444556666777
Other non-operating income4−332−211−3−401−10
Income before tax−29−23−16−17−16−36−20−16−11−12−13−12
Income tax expense1−3001−1110−900
Net income from continuing operations−29−21−16−17−17−35−21−17−11−3−13−12
Net income−29−21−16−17−17−35−21−17−11−3−13−12
EPS, basic−$1.12−$0.79−$0.58−$0.62−$0.60−$1.19−$0.70−$0.56−$0.38−$0.09−$0.45−$0.39
EPS, diluted−$1.12−$0.79−$0.58−$0.62−$0.60−$1.19−$0.70−$0.56−$0.38−$0.09−$0.45−$0.39
Weighted average shares, basic262628282829292930303030
Weighted average shares, diluted262628282829292930303030
EBITDA−24−17−10−10−9−28−11−7−2−2−31
Depreciation & amortization111222332335
EBIT−25−19−11−12−11−30−14−10−5−5−6−5